Letter sent to Healthcare Professionals: Levothyroxine from Teva UK Limited -

Letter sent to Healthcare Professionals: Levothyroxine from Teva UK Limited
Information type: Safety alerts
Source: Medicines and Healthcare products Regulatory Agency
Specialities: Endocrine system disorders
Summary
Teva UK Limited has reintroduced 50mcg and 100mcg levothyroxine tablets, together with 3 additional strengths: 12.5mcg, 25mcg and 75mcg tablets. These are all lactose-free.
UKMi comment
Levothyroxine has not been ordinarily available in strengths of 12.5mcg and 75mcg. The introduction of these may require additional counselling instructions to patients.
Related links: